A redesigned version of Moderna's Covid-19 booster shot appears to provide stronger protection against the omicron variant than its current vaccine, the company said in a news release Wednesday.

Its key findings were: The bivalent vaccines provided similar protection for the Omicron BA.4 and BA.5 subvariants and subsequent Omicron subvariants like BQ.1 and XBB. The Moderna COVID-19 ...

shows a "superior neutralizing antibody response" against the coronavirus compared to its original vaccine. The "bivalent" vaccine — meaning it targets two different antigens — is Moderna's ...

Children 6 months through 5 years of age who received the original Moderna COVID-19 vaccine are now eligible to receive a single booster of the updated bivalent vaccine at least two months after ...

Pfizer and Moderna's bivalent booster both use mRNA technology combining the original COVID-19 vaccine along with the reformulation targeting the BA.4 and BA.5 versions of the omicron variant.

Were the original Moderna and Pfizer-BioNTech Covid-19 mRNA vaccines tested ... OK, so what about the new bivalent booster vaccines designed to protect against both the original SARS-CoV-2 and ...

The updated (bivalent) Moderna booster can be given to anyone ... Johnson & Johnson’s COVID vaccine has a weakened version of the adenovirus, one of the viruses that causes the common cold.

Moderna's new version of its COVID-19 vaccine, which targets two virus variants ... achieve a more durable response than Moderna's first bivalent shot mRNA-1273.211, based on the original SARS ...

Last month, an average of about 350 people died each week from COVID, according to data from the CDC. With available vaccines ...

Moderna filed for FDA approval of its mRNA-1083 combination shot last year. The submission put the biotech on track to win ...

Moderna has reported preliminary clinical results with a bivalent version of its COVID-19 vaccine that combines its original version with another targeting the Beta variant, and seems to offer ...